Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: A randomized controlled trial (vol 110, pg 267, 2007)

被引：0
|
作者：
Van Wyck, D. B.
Martens, M. G.
Seid, M. H.
Baker, J. B.
Mangione, A.
机构：
来源：
OBSTETRICS AND GYNECOLOGY | 2008年 / 111卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：996 / 996
页数：1
相关论文
共 50 条
  • [11] Addition of oral iron bisglycinate to intravenous iron sucrose for the treatment of postpartum anemia-randomized controlled trial
    Yefet, Enav
    Rabah, Sobhiya Mruat
    Sela, Nitzan Dana
    Mhamed, Sally Hosary
    Yossef, Avishag
    Nachum, Zohar
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 225 (06) : 668.e1 - 668.e9
  • [12] Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
    Adkinson, N. Franklin
    Strauss, William E.
    Macdougall, Iain C.
    Bernard, Kristine E.
    Auerbach, Michael
    Kaper, Robert F.
    Chertow, Glenn M.
    Krop, Julie S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (05) : 683 - 690
  • [13] Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial (vol 28, pg 373, 2022)
    Howaldt, Stefanie
    Domenech, Eugeni
    Martinez, Nicholas
    Schmidt, Carsten
    Bokemeyer, Bernd
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (03) : 494 - 494
  • [14] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Bernd Froessler
    Tijana Gajic
    Gustaaf Dekker
    Nicolette A. Hodyl
    Archives of Gynecology and Obstetrics, 2018, 298 : 75 - 82
  • [15] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Ibrahim A. Abdelazim
    Bassam Nusair
    Shikanova Svetlana
    Gulmira Zhurabekova
    Archives of Gynecology and Obstetrics, 2018, 298 : 1231 - 1232
  • [16] Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials
    Barish, Charles F.
    Koch, Todd
    Butcher, Angelia
    Morris, David
    Bregman, David B.
    ANEMIA, 2012, 2012
  • [17] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Froessler, Bernd
    Gajic, Tijana
    Dekker, Gustaaf
    Hodyl, Nicolette A.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (01) : 75 - 82
  • [18] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Abdelazim, Ibrahim A.
    Nusair, Bassam
    Svetlana, Shikanova
    Zhurabekova, Gulmira
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (06) : 1231 - 1232
  • [19] Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
    Kanshaiym, Sakiyeva
    Zhurabekova, Gulmira
    Abdelazim, Ibrahim A.
    Starchenko, Tatyana
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (01) : 98 - 99
  • [20] ASSESSMENT OF INTRAVENOUS FERRIC CARBOXYMALTOSE VERSUS ORAL IRON SULPHATE IN THE MANAGEMENT OF PREOPERATIVE ANAEMIA: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
    Khalafallah, A.
    Chilvers, C. R.
    Sexton, M.
    Ingram, E.
    Chilvers, C. M.
    Vialle, M.
    Kirkby, B.
    Einoder, B.
    Brain, T.
    HAEMATOLOGICA, 2015, 100 : 334 - 335
12345